Jacques Pouysségur

Affiliations: 
University of Nice - Sophia Antipolis 
Google:
"Jacques Pouysségur"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Daher B, Vučetić M, Pouysségur J. (2020) Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death. Frontiers in Oncology. 10: 723
Cassim S, Vučetić M, Ždralević M, et al. (2020) Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer. Cancers. 12
Fabbri L, Dufies M, Lacas-Gervais S, et al. (2020) Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients. Theranostics. 10: 2696-2713
Renner K, Bruss C, Schnell A, et al. (2019) Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy. Cell Reports. 29: 135-150.e9
Guerrini G, Durivault J, Filippi I, et al. (2019) Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells. Biochemical and Biophysical Research Communications
Daher B, Parks SK, Durivault J, et al. (2019) Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival and tumor formation via nutrient and oxidative stresses. Cancer Research
Cormerais Y, Pagnuzzi-Boncompagni M, Schrötter S, et al. (2019) Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma. Journal of Cellular and Molecular Medicine
Vučetić M, Daher B, Durivault J, et al. (2019) Abstract 880: Genetic ablation of the cystine transporter xCT in pancreatic ductal adenocarcinoma inhibits mTORC1, growth, survival and tumor formation: Implications for potentiating chemosensitivityviaerastin Cancer Research. 79: 880-880
Brolih S, Parks SK, Vial V, et al. (2018) AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity. Bmc Cancer. 18: 249
Ambrosetti D, Dufies M, Dadone B, et al. (2018) The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma. Plos One. 13: e0193477
See more...